BRITTNEY MARIANNO: Open Payments
NPI 1881094696 · PROVO, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$465 in 23 payments from 14 companies in 2025. Trend: 2023 $416 · 2024 $353 · 2025 $465
Food & beverage: $465
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $98 |
| Corcept Therapeutics | 2 | $60 |
| Medtronic, Inc. | 2 | $53 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $49 |
| Axsome Therapeutics, Inc. | 2 | $42 |
| Biogen, Inc. | 2 | $35 |
| Neuronetics, Inc. | 1 | $30 |
| SHIELD THERAPEUTICS INC | 1 | $19 |
| Boston Scientific Corporation | 1 | $17 |
| Lilly USA, LLC | 1 | $17 |
Products named: VRAYLAR, Korlym, INCEPTIV, CAPLYTA, Auvelity, QULIPTA, ZURZUVAE, NEUROSTAR TMS THERAPY SYSTEM.
Industry payments across UT — which companies pay providers there.
